Takashi Ogura

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Combination Therapy

Idiopathic Pulmonary Fibrosis

Top Venues

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Ogura, Atsuhito Nakazawa
Unveiling the importance of evaluating the nutritional status in idiopathic pulmonary fibrosis patients with antifibrotic agent introduction. Respirology (Carlton, Vic.) (2023)
Sho Yamada, Satoshi Ikeda, Toshihiro Misumi, Akimasa Sekine, Takashi Ogura
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable. Respirology (Carlton, Vic.) 28 (2) (2022)
Sho Yamada, Satoshi Ikeda, Toshihiro Misumi, Akimasa Sekine, Takashi Ogura
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable. Respirology (Carlton, Vic.) (2022)
Sho Yamada, Satoshi Ikeda, Toshihiro Misumi, Akimasa Sekine, Takashi Ogura
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable. Respirology (Carlton, Vic.) 28 (2) (2022)
Sho Yamada, Satoshi Ikeda, Toshihiro Misumi, Akimasa Sekine, Takashi Ogura
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable. Respirology (Carlton, Vic.) (2022)
Sho Yamada, Satoshi Ikeda, Toshihiro Misumi, Akimasa Sekine, Takashi Ogura
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable. Respirology (Carlton, Vic.) 28 (2) (2022)
Jin Woo Song, Takashi Ogura, Yoshikazu Inoue, Zuojun Xu, Manuel Quaresma, Susanne Stowasser, Wibke Stansen, Bruno Crestani
Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON. Respirology (Carlton, Vic.) 25 (4) (2019)
Yasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, Taiki Furukawa, Masahiko Ando, Kenta Murotani, Michiaki Mishima, Yoshikazu Inoue, Takashi Ogura, Masashi Bando, Koichi Hagiwara, Takafumi Suda, Hirofumi Chiba, Hiroki Takahashi, Yukihiko Sugiyama, Sakae Homma
Disease severity staging system for idiopathic pulmonary fibrosis in Japan. Respirology (Carlton, Vic.) 22 (8) (2017)
Takashi Ogura, Hideya Kitamura
Tolerability of treatment with pirfenidone or nintedanib for pulmonary fibrosis in the real world. Respirology (Carlton, Vic.) 22 (6) (2017)